Testing a New Medication for Relapsing Multiple Sclerosis

This trial is testing how well a medication called ofatumumab works for people living with relapsing multiple sclerosis (a type of MS where symptoms flare up periodically). Researchers want to understand how effective and safe this medication is in Chinese patients and whether it can help slow down nerve damage. This treatment has already shown promise in other countries, but doctors need more real-world information to confirm it works well for this patient population.

While this medication has been shown to work well in international studies, there is limited data on how it performs in Chinese patients with relapsing multiple sclerosis. This trial aims to fill that gap and help doctors understand whether the medication is truly effective and safe for people with this condition in their specific healthcare setting.